Skip to content

Investors experiencing losses with Novo Nordisk A/S (NVO) urged to consider securities fraud investigation by the Law Offices of Howard G. Smith

Investigation by Law Offices of Howard G. Smith continues concerning Danish pharmaceutical company, Novo Nordisk A/S

Securities Fraud Investigation Launched: Novo Nordisk A/S (NVO) Shareholders Suffering Losses...
Securities Fraud Investigation Launched: Novo Nordisk A/S (NVO) Shareholders Suffering Losses Encouraged to Consult Law Offices of Howard G. Smith

Investors experiencing losses with Novo Nordisk A/S (NVO) urged to consider securities fraud investigation by the Law Offices of Howard G. Smith

In a recent development, pharmaceutical giant Novo Nordisk has found itself under investigation for possible violations of federal securities laws. The investigation is being conducted, but the name of the lawyer leading the probe remains undisclosed.

The investigation comes in the wake of Novo Nordisk ending its partnership with Hims & Hers Health, Inc. on June 23, 2025. Hims, a digital healthcare company, was accused of mass selling compounded drugs under the guise of 'personalization' and disseminating deceptive marketing that put patient safety at risk.

The allegations against Hims have had a ripple effect on Novo Nordisk. On the same day the partnership ended, Novo Nordisk's stock price fell $4.05, or 5.5%, to close at $69.72 per share. The fall continued on July 29, 2025, when the stock price plummeted $15.06, or 21.8%, to close at $53.94 per share.

The company also lowered sales growth expectations for its blockbuster drugs Ozempic and Wegovy due to a slowdown in market expansion, competition, and the alleged continued use of compounded GLP-1s. The slowdown in sales growth and operating profit prompted Novo Nordisk to cut its previously issued guidance.

Investors who have suffered a loss as a result of these developments can potentially pursue claims to recover their losses. The Law Offices of Howard G. Smith, a law firm based in Bensalem, Pennsylvania, is contacting investors who purchased Novo Nordisk securities.

The Law Offices of Howard G. Smith can be reached at 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by phone at (215) 638-4847, or by email at [email protected]. The firm's website is www.howardsmithlaw.com.

Investors are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights. It is important to note that this press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

This press release is from Business Wire.

Read also:

Latest